Next report date
Report period
Q1 2024
EPS estimate
−6.22USD
Revenue estimate
—
−19.95USD
−373.63 MUSD
17.08 M
About Madrigal Pharmaceuticals, Inc.
Sector
CEO
William J. Sibold
Headquarters
West Conshohocken
Website
Employees (FY)
376
Founded
2011
FIGI
BBG00JVRDW18
Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0JXI is 193.75 USD — it has decreased by 2.80% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange MADRIGAL PHARMACEUTICALS INC USD0.0001 stocks are traded under the ticker 0JXI.
MADRIGAL PHARMACEUTICALS INC USD0.0001 is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
0JXI stock is 4.94% volatile and has beta coefficient of 1.88. Check out the list of the most volatile stocks — is MADRIGAL PHARMACEUTICALS INC USD0.0001 there?
0JXI earnings for the last quarter are −5.34 USD per share, whereas the estimation was −4.90 USD resulting in a −9.08% surprise. The estimated earnings for the next quarter are −5.24 USD per share. See more details about MADRIGAL PHARMACEUTICALS INC USD0.0001 earnings.
Yes, you can track MADRIGAL PHARMACEUTICALS INC USD0.0001 financials in yearly and quarterly reports right on TradingView.
0JXI stock has fallen by 12.16% compared to the previous week, the month change is a 22.62% fall, over the last year MADRIGAL PHARMACEUTICALS INC USD0.0001 has showed a 35.92% decrease.
0JXI net income for the last quarter is −112.19 M USD, while the quarter before that showed −98.74 M USD of net income which accounts for −13.63% change. Track more MADRIGAL PHARMACEUTICALS INC USD0.0001 financial stats to get the full picture.
Today MADRIGAL PHARMACEUTICALS INC USD0.0001 has the market capitalization of 4.06 B, it has decreased by 8.37% over the last week.
No, 0JXI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0JXI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MADRIGAL PHARMACEUTICALS INC USD0.0001 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 28, 2024, the company has 376.00 employees. See our rating of the largest employees — is MADRIGAL PHARMACEUTICALS INC USD0.0001 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MADRIGAL PHARMACEUTICALS INC USD0.0001 technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MADRIGAL PHARMACEUTICALS INC USD0.0001 stock shows the sell signal. See more of MADRIGAL PHARMACEUTICALS INC USD0.0001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MADRIGAL PHARMACEUTICALS INC USD0.0001 future price: according to them, 0JXI price has a max estimate of 565.00 USD and a min estimate of 150.00 USD. Read a more detailed MADRIGAL PHARMACEUTICALS INC USD0.0001 forecast: see what analysts think of MADRIGAL PHARMACEUTICALS INC USD0.0001 and suggest that you do with its stocks.